Classification of different patterns of pulmonary adenocarcinomas

References

• De la Cruz CS, Tanoue LT, Matthay RA. Lung Cancer: Epidemiology, Etiology, and Prevention. Clin Chest Med 2011;32:605-44
   PubMed Web of Science ®Google Scholar
• Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers—a different disease. Nat Rev Cancer 2007;7:778-90
   PubMed Web of Science ®Google Scholar
• Devarakonda S, Morgenszterm D, Govindan M. Genomic alterations in lung adenocarcinoma. Lancet Oncol 2015;16:e342-51
   PubMed Web of Science ®Google Scholar
• Pao W, Iafrate JA, Su Z. Genetically informed lung cancer medicine. J Pathol 2011;223:230-40
   PubMed Web of Science ®Google Scholar
• Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008;455:1069-75
   PubMed Web of Science ®Google Scholar
• Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-39
   PubMed Web of Science ®Google Scholar
• Paez JG, Jänne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497-500
   PubMed Web of Science ®Google Scholar
• Pao W, Miller V, Zakowski M, et al. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 2004;101:13306-11
   PubMed Web of Science ®Google Scholar
• Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small cell lung cancer. Nature 2007;448:561-6
   PubMed Web of Science ®Google Scholar
• Tiseo M, Gelsomino F, Bartolotti M, et al. Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer. Expert Rev Anticancer Ther 2011;11:1677-87
   PubMed Web of Science ®Google Scholar
• Gainor JF, Shaw AT. Novel targets in non-small cell lung cancer: ROS1 and RET fusions. Oncologist 2013;18:865-75
   PubMed Web of Science ®Google Scholar
• Wang R, Hu H, Pan Y, et al. RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer. J Clin Oncol 2012;30:4352-9
   PubMed Web of Science ®Google Scholar
• Tsuta K, Kohno T, Yoshida A, et al. RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis. Br J Cancer 2014;110:1571-8
   PubMed Web of Science ®Google Scholar
• Fernandez-Cuesta L, Plenker D, Osada H, et al. CD74-NRG1 fusions in lung adenocarcinoma. Cancer Discov 2014;4:415-22
   PubMed Web of Science ®Google Scholar
• Nakaoku T, Tsuta K, Ichikawa H, et al. Druggable oncogene fusions in invasive mucinous lung adenocarcinoma. Clin Cancer Res 2014;20:3087-93
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-85
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Burke AP, et al. WHO Classification of tumours of the lung, pleura, thymus and heart. International Agency for Research on Cancer IARC; Lyon: 2015
   Google Scholar
• Takeuchi T, Tomida S, Yatabe Y, et al. Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol 2006;24:1679-88
   PubMed Web of Science ®Google Scholar
• Arima C, Kajino T, Tamada Y, et al. Lung adenocarcinoma subtypes definable by lung development-related miRNA expression profiles in association with clinicopathologic features. Carcinogenesis 2014;35:2224-31
   PubMed Web of Science ®Google Scholar
• Yatabe Y, Kosaka T, Takahashi T, Mitsudomi T. EGFR mutation is specific for terminal respiratory unit type adenocarcinoma. Am J Surg Pathol 2005;29:633-9
   PubMed Web of Science ®Google Scholar
• Yoshida A, Tsuta K, Nakamura H, et al. Comprehensive histologic analysis of ALK-rearranged lung carcinomas. Am J Surg Pathol 2011;35:1226-34
   PubMed Web of Science ®Google Scholar
• Inamura K, Takeuchi K, Togashi Y, et al. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset. Mod Pathol 2009;22:508-15
   PubMed Web of Science ®Google Scholar
• Yoshida A, Kohno T, Tsuta K, et al. ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases. Am J Surg Pathol 2013;37:554-62
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Pennell NA, Ali SM, et al. RET-rearranged lung adenocarcinomas with lymphangitic spread, psammoma bodies, and clinical responses to cabozantinib. J Thorac Oncol 2014;9:1714-19
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang R, Cai D, et al. A comprehensive investigation of molecular features and prognosis of lung adenocarcinoma with micropapillary component. J Thorac Oncol 2014;9:1772-8
   PubMed Web of Science ®Google Scholar
• Hu H, Pan Y, Li Y, et al. Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma. Onco Targets Ther 2014;7:1423-37
   PubMed Web of Science ®Google Scholar
• Pan Y, Zhang Y, Li Y, et al. ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features. Lung Cancer 2014;84:121-6
   PubMed Web of Science ®Google Scholar
• Sartori G, Cavazza A, Sgambato A, et al. EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors. Am J Clin Pathol 2009;131:478-89
   PubMed Web of Science ®Google Scholar
• Kadota K, Yeh YC, D’Angelo SP, et al. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation. Am J Surg Pathol 2014;38:1118-27
   PubMed Web of Science ®Google Scholar
• Morales-Oyarvide V, Mino-Kenudson M. High-grade lung adenocarcinomas with micropapillary and/or solid patterns: a review. Curr Opin Pulm Med 2014;20:317-23
   PubMed Web of Science ®Google Scholar
• Tsuta K, Kawago M, Yoshida A, et al. Primary lung adenocarcinoma with morule-like components: a unique histologic hallmark of aggressive behavior and EGFR mutation. Lung Cancer 2014;85:12-18
   PubMed Web of Science ®Google Scholar
• Weichert W, Warth A. Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma. Curr Opin Pulm Med 2014;20:309-16
   PubMed Web of Science ®Google Scholar
• Villa C, Cagle PT, Johnson M, et al. Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society. Arch Pathol Lab Med 2014;138:1353-7
   PubMed Web of Science ®Google Scholar
• Yatabe Y, Mitsudomi T. Epidermal growth factor receptor mutations in lung cancers. Pathol Int 2007;57:233-44
   PubMed Web of Science ®Google Scholar
• Rossi G, Graziano P, Leone A, et al. The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas. Semin Diagn Pathol 2013;30:298-312
   PubMed Web of Science ®Google Scholar
• Austin JHM, Garg K, Aberle D, et al. Radiologic implications of the 2011 classification of adenocarcinoma of the lung. Radiology 2013;266:62-71
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Noguchi M, et al. Diagnosis of lung adenocarcinoma in resected specimens. implications of the international association for the study of lung cancer/american thoracic society/european respiratory society classification. Arch Pathol Lab Med 2013;137:658-705
   Google Scholar
• Travis WD, Brambilla E, Noguchi M, et al. Diagnosis of lung cancer in small biopsies and cytology. Implications of the 2011 international association for the study of lung cancer/american thoracic society/european respiratory society classification. Arch Pathol Lab Med 2013;137:668-84
   PubMed Web of Science ®Google Scholar
• Xu CH, Wang W, Wei Y, et al. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma. Eur J Surg Oncol 2015. [Epub ahead of print]
   Google Scholar
• Warth A, Muley T, Meister M, et al. The novel histologic international association for the study of lung cancer/american thoracic society/european respiratory society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 2012;30:1438-46
   PubMed Web of Science ®Google Scholar
• Kadota K, Villena-Vargas J, Yoshizawa A, et al. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease. Am J Surg Pathol 2014;38:448-60
   PubMed Web of Science ®Google Scholar
• Yoshizawa A, Sumiyoshi S, Sonobe M, et al. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol 2013;8:52-61
   PubMed Web of Science ®Google Scholar
• Travis WD, Brambilla E, Riely GJ. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. J Clin Oncol 2013;31:992-1001
   PubMed Web of Science ®Google Scholar
• Kadota K, Yeh YC, Sima CS, et al. The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype. Mod Pathol 2014;27:690-700
   PubMed Web of Science ®Google Scholar
• Kadota K, Colovos C, Suzuki K, et al. FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma. Ann Surg Oncol 2012;19:3598-605
   PubMed Web of Science ®Google Scholar
• Lantuejoul S, Salameire D, Salon C, et al. Pulmonary preneoplasia - sequential molecular carcinogenetic events. Histopathology 2009;54:43-54
   PubMed Web of Science ®Google Scholar
• Sartori G, Cavazza A, Bertolini F, et al. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotipically related. An EGFR, HER2, and K-ras mutational analysis. Am J Clin Pathol 2008;129:202-10
   PubMed Web of Science ®Google Scholar
• Chapman AD, Kerr KM. The association between atypical adenomatous hyperplasia and primary lung cancer. Br J Cancer 2000;83:632-6
   PubMed Web of Science ®Google Scholar
• Travis WD, Colby TV, Corrin B, et al. WHO histological classification of tumors. Histological typing of lung and pleural tumours. Springer-Verlag; Berlin, Germany: 1999
   Google Scholar
• Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and Genetics: Tumors of the Lung, Pleura, Thymus and Heart. IARC; Lyon, France: 2004
   Google Scholar
• Park WY, Kim MH, Shin DH, et al. Ciliated adenocarcinomas of the lung: a tumor of non-terminal respiratory unit origin. Mod Pathol 2012;25:1265-74
   PubMed Web of Science ®Google Scholar
• Chilosi M, Murer B. Mixed adenocarcinomas of the lung. Place in new proposals in classification, mandatory for target therapy. Arch Pathol Lab Med 2010;134:55-65
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Mitsudomi T, Sakao Y, Yatabe Y. Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth. Ann Oncol 2015;26:156-61
   PubMed Web of Science ®Google Scholar
• Rossi G, Pelosi G, Barbareschi M, et al. Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice. Int J Surg Pathol 2013;21:326-36
   PubMed Web of Science ®Google Scholar
• Lederlin M, Puderbach M, Muley T, et al. Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma. Eur Respir J 2013;41:943-51
   PubMed Web of Science ®Google Scholar
• Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer 1995;75:2844-52
   PubMed Web of Science ®Google Scholar
• Sakurai H, Maeshima A, Watanabe S, et al. Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol 2004;28:198-206
   PubMed Web of Science ®Google Scholar
• Yim J, Zhu LC, Chiriboga L, et al. Histologic features are important prognostic indicators in early stages lung adenocarcinomas. Mod Pathol 2007;20:233-41
   PubMed Web of Science ®Google Scholar
• Borczuk AC, Qian F, Kazeros A, et al. Invasive size is an independent predictor of survival in pulmonary adenocarcinoma. Am J Surg Pathol 2009;33:462-9
   PubMed Web of Science ®Google Scholar
• Maeshima AM, Tochigi N, Yoshida A, et al. Histological scoring for small lung adenocarcinomas 2 cm or less in diameter: a reliable prognostic indicator. J Thor Oncol 2010;5:333-9
   PubMed Web of Science ®Google Scholar
• Borczuk AC. Assessment of invasion in lung adenocarcinoma classification, including adenocarcinoma in situ and minimally invasive adenocarcinoma. Mod Pathol 2012;25:S1-S10
   PubMedGoogle Scholar
• Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011;24:653-64
   PubMed Web of Science ®Google Scholar
• Xu L, Tavora F, Burke A. Histologic features associated with metastatic potential in invasive adenocarcinoma of the lung. Am J Surg Pathol 2013;37:1100-8
   PubMed Web of Science ®Google Scholar
• Hishida T, Ishii G, Kodama T, et al. Centrally located adenocarcinoma with endobronchial polypoid growth: clinicopathological analysis of five cases. Pathol Intern 2011;61:73-9
   PubMed Web of Science ®Google Scholar
• Koss M, Travis WD, Moran C, et al. Pseudomesotheliomatous adenocarcinoma: a reappraisal. Semin Diagn Pathol 1992;9:117-23
   PubMed Web of Science ®Google Scholar
• Khan KA, Kennedy MP, Moore E, et al. Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis. Lung 2015;193:71-7
   PubMed Web of Science ®Google Scholar
• Lantuejoul S, Nicholson AG, Sartori G, et al. Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors. Am J Surg Pathol 2007;31:961-9
   PubMed Web of Science ®Google Scholar
• Girard N, Deshpande C, Lau C, et al. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases. Am J Surg Pathol 2009;33:1752-64
   PubMed Web of Science ®Google Scholar
• Rodriguez EF, Monaco SE, Dacic S. Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification. Cancer Cytopathol 2015;123:306-17
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang Y, Zhou X, et al. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity. Lung Cancer 2015;87:272-7
   PubMed Web of Science ®Google Scholar
• Chen Z, Liu X, Zhao J, et al. Correlation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification of lung adenocarcinoma. Int J Clin Exp Pathol 2014;7:8039-45
   PubMedGoogle Scholar
• de Melo AC, Karen de Sá V, Sternberg C, et al. Mutational Profile and New IASLC/ATS/ERS classification provide additional prognostic information about lung adenocarcinoma: a study of 125 Patients from Brazil. Oncology 2015. [Epub ahead of print]
   PubMedGoogle Scholar
• Mackinnon ACJr, Luevano A, de Araujo LC, et al. Cribriform adenocarcinoma of the lung: clinicopathologic, immunohistochemical, and molecular analysis of 15 cases of a distinctive morphologic subtype of lung adenocarcinoma. Mod Pathol 2014;27:1063-72
   PubMed Web of Science ®Google Scholar
• Nakamura H, Saji H, Shinmyo T, et al. Association of IASLC/ATS/ERS Histologic Subtypes of Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutations in 320 Resected Cases. Clin Lung Cancer 2015;16:209-15
   PubMed Web of Science ®Google Scholar
• Silver SA, Askin FB. True papillary carcinoma of the lung. A distinct clinicopathologic entity. Am J Surg Pathol 1997;21:43-51
   PubMed Web of Science ®Google Scholar
• Fornelli A, Cavazza A, Cancellieri A, et al. Bronchioloalveolar carcinoma with nodular (“morule-like”) features. Virchows Arch 2003;442:407-8
   PubMed Web of Science ®Google Scholar
• Moran CA, Jagirdar J, Suster S. Papillary lung carcinoma with prominent “morular” component. Am J Clin Pathol 2004;122:106-9
   PubMed Web of Science ®Google Scholar
• Amin MB, Tamboli P, Merchant SH, et al. Micropapillary component in lung adenocarcinoma. A distinctive histologic feature with possible prognostic significance. Am J Surg Pathol 2002;26:358-64
   PubMed Web of Science ®Google Scholar
• Miyoshi T, Satoh Y, Okumura S, et al. Early-stage lung adenocarcinoma with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol 2003;27:101-9
   PubMed Web of Science ®Google Scholar
• Kawakami T, Nabeshima K, Makimoto Y, et al. Micropapillary pattern and grade of stromal invasion in pT1 adenocarcinoma of the lung: usefulness as prognostic marker. Mod Pathol 2007;20:514-21
   PubMed Web of Science ®Google Scholar
• Tsutsumida H, Nomoto M, Goto M, et al. A micropapillary pattern is predictive of poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis. Mod Pathol 2007;20:638-47
   PubMed Web of Science ®Google Scholar
• Yeh YC, Wu YC, Chen CY, et al. Stromal invasion and micropapillary pattern in 212 consecutive surgically resected stage I lung adenocarcinomas: histopathological categories for prognosis prediction. J Clin Pathol 2012;65:910-18
   PubMed Web of Science ®Google Scholar
• Lee G, Lee HY, Jeong JY, et al. Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: prognostic significance and survival outcomes. Am J Surg Pathol 2015;39:660-6
   PubMed Web of Science ®Google Scholar
• Chao L, Yi-Sheng H, Yu C, et al. Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in Chinese patients. Lung Cancer 2014;86:164
   PubMed Web of Science ®Google Scholar
• Russell PA, Barnett SA, Walkiewicz M, et al. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients. J Thorac Oncol 2013;8:461-8
   PubMed Web of Science ®Google Scholar
• Xu S, Xi J, Jiang W, et al. Solid component and tumor size correlate with prognosis of stage IB lung adenocarcinoma. Ann Thorac Surg 2015;99:961-7
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li J, Wang R, et al. The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma. Sci Rep 2014;4:7163
   PubMed Web of Science ®Google Scholar
• Rekhtman N, Ang DC, Riely GJ, et al. KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma. Mod Pathol 2013;26:1307-19
   PubMed Web of Science ®Google Scholar
• Warth A, Penzel R, Lindenmaier H, et al. EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype. Eur Respir J 2014;43:872-8
   PubMed Web of Science ®Google Scholar
• Sugano M, Nagasaka T, Sasaki E, et al. HNF4α as a marker for invasive mucinous adenocarcinoma of the lung. Am J Surg Pathol 2013;37:211-18
   PubMed Web of Science ®Google Scholar
• Rossi G, Murer B, Cavazza A, et al. Primary mucinous (so-called colloid) carcinomas of the lung. A clinicopathologic and immunohistochemical study with special reference to CDX2 homeobox gene and MUC2 expression. Am J Surg Pathol 2004;28:442-52
   PubMed Web of Science ®Google Scholar
• Miyata N, Endo M, Nakajima T, et al. High-resolution computed tomography findings of early mucinous adenocarcinomas and their pathologic characteristics in 22 surgically resected cases. Eur Radiol J 2015;84:993-7
   PubMed Web of Science ®Google Scholar
• Cai D, Li H, Wang R, et al. Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma. Onco Targets Ther 2014;7:2127-32
   PubMed Web of Science ®Google Scholar
• Qu Y, Che N, Zhao D, et al. The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma. Tumour Biol 2015. [Epub ahead of print]
   Google Scholar
• Gow CH, Wu SG, Chang YL, et al. Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: identification of a rare CD74-NRG1 translocation case. Med Oncol 2014;31:34
   PubMed Web of Science ®Google Scholar
• Zenali MJ, Weissfedt A, Solis LM, et al. An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung. Hum Pathol 2015;46:836-42
   PubMed Web of Science ®Google Scholar
• Morita S, Yoshida A, Goto A, et al. High-grade lung adenocarcinoma with fetal lung-like morphology. Clinicopathologic, immunohistochemical, and molecular analysis of 17 cases. Am J Surg Pathol 2013;37:924-32
   PubMed Web of Science ®Google Scholar
• Inamura K, Satoh Y, Okumura S, et al. Pulmonary adenocarcinomas with enteric differentiation. Histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas. Am J Surg Pathol 2005;29:660-5
   PubMed Web of Science ®Google Scholar
• Boland JM, Wampfler JA, Jang JS, et al. Pulmonary adenocarcinoma with signet ring cell features: a comprehensive study from 3 distinct patient cohorts. Am J Surg Pathol 2014;38:1681-8
   PubMed Web of Science ®Google Scholar
• Iwasaki T, Ohta M, Lefor AT, et al. Signet-ring cell carcinoma component in primary lung adenocarcinoma: potential prognostic factor. Histopathology 2008;52:631-56
   PubMed Web of Science ®Google Scholar
• Pareja F, Crapanzano JP, Mansukhani MM, et al. Cytomorphological features of ALK-positive lung adenocarcinomas: psammoma bodies and signet ring cells. Cancer Cytopathol 2015;123:162-70
   PubMed Web of Science ®Google Scholar
• Solis LM, Raso G, Kalhor N, et al. Primary oncocytic adenocarcinoma of the lung. A clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases. Am J Clin Pathol 2010;133:133-40
   PubMed Web of Science ®Google Scholar
• Onozato ML, Kovach AE, Yeap BY, et al. Tumor islands in resected early-stage lung adenocarcinoma are associated with unique clinicopathologic and molecular characteristics and worse prognosis. Am J Surg Pathol 2013;37:287-94
   PubMed Web of Science ®Google Scholar
• Maeda H, Matsumura A, Kawabata T, et al. Adenosquamous carcinoma of the lung: surgical results as compared with squamous cell and adenocarcinoma cases. Eur J Cardio-Thorac Surg 2012;41:357-61
   PubMed Web of Science ®Google Scholar
• Tochigi N, Dacic S, Nikiforova M, et al. Adenosquamous Carcinoma of the Lung A Microdissection Study of KRAS and EGFR Mutational and Amplification Status in a Western Patient Population. Am J Clin Pathol 2011;135:783-9
   PubMed Web of Science ®Google Scholar
• Lin D, Jiang Y, Wang J, et al. Pulmonary mixed squamous cell and glandular papilloma mimicking adenocarcinoma: a case study and literature review. J Thorac Dis 2013;5:E129-32
   PubMedGoogle Scholar
• Rekhtman N, Paik PK, Arcila ME, et al. Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations. Clin Cancer Res 2012;18:1167-76
   PubMed Web of Science ®Google Scholar
• Kadota K, Suzuki K, Kachala SS, et al. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma. Mod Pathol 2012;25:1117-27
   PubMed Web of Science ®Google Scholar
• von der Thusen JH, Tham YS, Pattenden H, et al. Prognostic significance of predominant histologic pattern and nuclear grade in resected adenocarcinoma of the lung. Potential parameters for a grading system. J Clin Oncol 2013;8:37-44
   Web of Science ®Google Scholar
• Sica G, Yoshizawa A, Sima CS, et al. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol 2010;34:1155-62
   PubMed Web of Science ®Google Scholar
• Warth A, Stenzinger A, von Brunneck AC, et al. Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas. Eur Respir J 2012;40:1221-7
   PubMed Web of Science ®Google Scholar
• Thunnissen E, Beasley MB, Borczuk AC, et al. Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study. Mod Pathol 2012;25:1574-83
   PubMed Web of Science ®Google Scholar
• Rodriguez EF, Dacic S, Pantanowitz L, et al. Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed international association for the study of lung cancer/american thoracic society/european respiratory society (IASLC/ATS/ERS) classification. Cancer Cytopathol 2015;123(5):306-17
   PubMed Web of Science ®Google Scholar
• Yeh YC, Nitadori J, Kadota K, et al. Using frozen section to identify histological patterns in stage I lung adenocarcinoma of < 3cm: accuracy and interobserver agreement. Histopathology 2015;66:922-38
   PubMed Web of Science ®Google Scholar
• Trejo Bittar HE, Incharoen P, Althouse AD, Dacic S. Accuracy of the IALSC/ATS/ERS histological subtyping of stage I lung adenocarcinoma on intraoperative frozen sections. Mod Pathol 2015. [Epub ahead of print]
   PubMedGoogle Scholar
• Mani H, Zander DS. Immunohistochemistry. Applications to the Evaluation of Lung and Pleural Neoplasms: Part 1. Chest 2012;142:1316-23
   PubMed Web of Science ®Google Scholar
• Bishop JA, Sharma R, Illei PB. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol 2010;41:20-2
   PubMed Web of Science ®Google Scholar
• Pelosi G, Rossi G, Cavazza A, et al. Np63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization. Int J Surg Pathol 2013;21:229-39
   PubMed Web of Science ®Google Scholar
• Lewis DR, Check DP, Caporaso NE, et al. US lung cancer trends by histologic type. Cancer 2014;120:2883-92
   PubMed Web of Science ®Google Scholar
• van der Heijden EH, Casal RF, Trisolini R, et al. Guideline for the acquisition and preparation of conventional and endobronchial ultrasound-guided transbronchial needle aspiration specimens for the diagnosis and molecular testing of patients with known or suspected lung cancer. Respiration 2014;88:500-17
   PubMed Web of Science ®Google Scholar
• Thunnissen E, Bubendorf L, Dietel M, et al. EML4–ALK testing in nonsmall cell carcinomas of the lung: a review with recommendations. Virchows Arch 2012;461:245-57
   PubMed Web of Science ®Google Scholar
• Coley SM, Crapanzano JP, Saqi A. FNA, core biopsy, or both for the diagnosis of lung acrcinoma: obtaining sufficient tissue for a specific diagnosis and molecular testing. Cancer Cytopathol 2015;123:318-26
   PubMed Web of Science ®Google Scholar